Abstrait

The Case of Rufomyazine and Rufomycin: Residual Complexity Does Impact Organic Chemistry and Drug Discovery

Emily Miller*

The intriguing monograph by the late Robert Shapiro noted, the question of our beginnings is a glorious one. How did we get to our modern biology, which looks to be incredibly different but uses the same basic mechanisms and building blocks practically everywhere? Such a loaded topic has undoubtedly produced a number of theories, some of which Shapiro better defines as myths because they do not hold up to scientific investigation.